Clinical Study

Clinical Outcomes of Peripheral Iridotomy in Patients with the Spectrum of Chronic Primary Angle Closure

Table 2

Summary of primary outcomes after PI.

Variable All Eyes
( )
PAC spectrum diseaseTreatment
PACS
( )
CPAC
( )
CPACG
( )
PI only
( )
PI + Iridoplasty
( )

Followup duration (months), mean ± SD57.1 ± 29.054.4 ± 36.960.9 ± 26.355.1 ± 23.154.5 ± 36.371.7 ± 39.4
Additional medical and surgical treatments, (%)68 (86.1)18 (72.0)28 (93.3)22 (91.7)56 (83.6) 12 (100)
Additional glaucoma treatments, (%)51 (64.6)7 (28.0)24 (80.0)20 (83.3)42 (62.7)9 (75.0)
 Medical treatment only287156244
 Glaucoma surgery (GS)*230914185
Cataract extraction (CE) procedure, (%)40 (50.6)13 (52.0)16 (53.3)11 (45.8)34 (50.8)6 (50.0)
Additional surgery (CE or GS), (%)48 (60.8)13 (52.0)18 (60.0)17 (70.8)40 (59.7)8 (66.7)
 CE only251393223
 GS only802662
 Combined CE and GS 503250
 GS first then CE703452
 CE first then GS301221
Clinical impression of visual field/optic disc progression, (%)14 (17.7)2 (8.0)3 (10.0)9 (37.5)13 (19.4)1 (8.3)
 Visual field only401340
 Optic disc only611451
 Both visual field and optic disc411240

CE: cataract extraction; GS: glaucoma surgery; PACS: primary angle closure suspect; CPAC: chronic primary angle closure; CPACG: chronic primary angle closure glaucoma.
Glaucoma surgery was performed after medical treatment, except for one PAC eye which was never on medications during followup.